Wollny Tomasz, Chabielska Ewa, Malinowska-Zaprzałka Małgorzata, Nazarko Joanna, Rozmysłowicz-Szermińska Wioletta, Buczko Włodzimierz
Department of Pharmacodynamics, Medical University, Mickiewicza 2c, PL 15-089 Białystok, Poland.
Pol J Pharmacol. 2003 Nov-Dec;55(6):1089-96.
A number of epidemiological studies have demonstrated that moderate red wine consumption significantly decreases the risk of ischemic heart disease. Our earlier studies provide evidence that Italian red wine modulates primary hemostasis and prevents experimental venous thrombosis in rats, independently of its alcohol content, by a nitric oxide (NO)-mediated mechanism. In the present study, we have tested whether Bulgarian red and white wines can influence thrombotic process and primary hemostasis in rats. NO and PGI2 were evaluated as possible mediators of these effects. We have found that red wine treatment (for 10 days) induced a marked prolongation of bleeding time, decrease in platelet adhesion to fibrillar collagen, reduction in venous thrombus weight and shortening of occlusion time in arterial thrombosis model. The fall in venous thrombus weight was also observed after white wine supplementation. Red wine affects hemostasis and venous thrombosis after its iv injection 15 min before experiment. These effects were prevented by NO inhibitor (L-NAME) and PGI2 inhibitor (indomethacin). Our results demonstrate the ability of Bulgarian wines to modulate primary hemostasis and prevent venous and arterial thrombosis in rat.
多项流行病学研究表明,适量饮用红酒可显著降低缺血性心脏病的风险。我们早期的研究提供了证据,表明意大利红酒通过一氧化氮(NO)介导的机制,独立于其酒精含量,调节大鼠的初级止血并预防实验性静脉血栓形成。在本研究中,我们测试了保加利亚红酒和白酒是否会影响大鼠的血栓形成过程和初级止血。评估了NO和前列环素(PGI2)作为这些作用的可能介质。我们发现,红酒处理(持续10天)可显著延长出血时间,减少血小板与纤维状胶原蛋白的黏附,减轻静脉血栓重量,并缩短动脉血栓形成模型中的闭塞时间。补充白酒后也观察到静脉血栓重量下降。在实验前15分钟静脉注射红酒后,其会影响止血和静脉血栓形成。这些作用可被NO抑制剂(L-精氨酸甲酯)和PGI2抑制剂(吲哚美辛)阻断。我们的结果证明了保加利亚葡萄酒调节大鼠初级止血并预防静脉和动脉血栓形成的能力。